Join us in

16 Days 07 H 13 Min 55 Sec

Reading Writing & Editing DNA
Reading Writing & Editing DNA
Reading Writing & Editing DNA
May 5-8

2025

San Jose Convention Center
California, USA
May 5-8

2025

San Jose
Convention Center
California, USA

About

Track Chair
Rob Carlson

Planetary Technologies

Managing Director

The triad of reading, writing, and editing DNA forms the foundational bedrock of synthetic biology. With burgeoning insights into DNA and advancements in its synthesis, our comprehension and mastery over technologies such as CRISPR, cell-free manufacturing, protein design, and molecular data storage have intensified. This engineering vision, once nascent, has now metamorphosed into tangible applications, facilitating the remediation of diseases, sustainable chemical production, molecular data preservation, and the synthesis of unique proteins absent in the natural realm. Such advancements inevitably prompt contemplation on the subsequent innovations birthed from the intricate manipulation of DNA.

Agenda

Agenda

Monday

May 05

Tuesday

May 06
Pushing Scientific Possibilities and Traceability of Pristine DNA Molecules Through Algorithm-Driven DNA Assembly
2:55 PM

-

3:05 PM

Inadequate DNA synthesis technologies are stalling scientific advancements and cannot meet the increasing demand for high-complexity, sequence-perfect molecules. Now, algorithm-driven technology is redefining scientific possibility by delivering pristine synthetic DNA molecules towards transformative solutions for the health of people and the planet. By combining intelligent algorithms, proprietary enzymatic assembly, adaptive automation, and end-to-end traceability from sequence to molecule, we can overcome the inefficiencies of traditional methods to produce highly accurate, long, and complex DNA ready for immediate use. These solutions are now commercially available, enabling researchers to unlock innovations in advanced therapeutics, vaccines, synthetic biology, and accelerate progress across the industry.

Empowering Breakthroughs: How Synthetic DNA is Redefining Scientific Possibilities
4:30 PM

-

5:15 PM

Commercial solutions providing synthetic DNA molecules have overcome some of the most challenging manufacturing hurdles, now providing molecules of varying and exceeding length, complexity, and accuracy. These advancements are enabling new possibilities and unlocking vast potential for a range of applications. In this interactive panel, we will bring together leading experts to discuss latest market advancements, innovative approaches utilizing synthetic DNA, and the transformative potential of these solutions.Join us for this discussion as we explore the potential of synthetic DNA and how it can unlock innovations for better health of people and planet.

Wednesday

May 07
Reading and Writing: How Far, How Fast, & When?
11:25 AM

-

11:55 AM

This session will examine the frontiers of genomic sequencing and synthesis, providing a critical assessment of the present capabilities and charting likely trajectories for future progress. Participants will highlight the latest advances in instrumentation, informatics, and automation that are pushing beyond conventional limits, while also considering emerging technologies poised to reshape the landscape of DNA reading and writing. By focusing on accuracy, throughput, and scalability, this discussion will illuminate the fundamental shifts now taking place and the new horizons they open for biological research and innovation.

Thursday

May 08
Deconstructing Cellular Diversity: Single-Cell Sequencing for Drug Discovery and Synthetic Biology
2:30 PM

-

3:15 PM

This session will highlight how single-cell sequencing technologies are transforming our ability to identify novel therapeutic targets, optimize engineered cell lines, and accelerate the drug discovery pipeline. By dissecting cellular heterogeneity at unprecedented resolution, these approaches are revealing intricate gene-expression patterns and pathway dynamics that guide the design of synthetic biological systems with greater precision. From refining the selection of promising drug candidates to informing the rational engineering of cell-based models, the discussion will explore how single-cell insights are redefining the frontiers of synthetic biology and unlocking new opportunities for innovative drug discovery.

Conference Pass

2,495

USD

Keynotes & Firesides

Workshops & Breakouts

1:1 Partnering App

Meals & Receptions

Session Recordings

Until Friday April 18th

Full Rate:

$3,495

Related Topics

Copyright SynBioBeta 2025